Back
Pliant Therapeutics Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
PLRX
Pliant Therapeutics
Last Price:
12.49
Seasonality Move:
-10.54%
7 Day Trial
ALL ACCESS PASS
$
7
Former Chicago Pit Trader Exposes Shocking Trading Advantage:
See How to Target Up to 383% OVERNIGHT- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.41 | Buy |
| 20-day SMA: | 12.91 | Sell |
| 50-day SMA: | 12.85 | Sell |
| 200-day SMA: | 14.26 | Sell |
| 8-day EMA: | 12.4 | Buy |
| 20-day EMA: | 12.65 | Sell |
| 50-day EMA: | 12.72 | Sell |
| 200-day EMA: | 14.08 | Sell |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 48.91 | Sell |
| Chaikin Money Flow: | 215090 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.27 - 13.37) | Sell |
| Bollinger Bands (100): | (11.45 - 13.77) | Sell |
Pliant Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 12.60 while PLRX 8-day simple moving average is 12.41, which is a Buy signal.
- The stock price of PLRX is 12.60 while Pliant Therapeutics 20-day SMA is 12.91, which makes it a Sell.
- Pliant Therapeutics 50-day simple moving average is 12.85 while PLRX share price is 12.60, making it a Sell technically.
- PLRX stock price is 12.60 and Pliant Therapeutics 200-day simple moving average is 14.26, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
39
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Sell
The current Pliant Therapeutics [PLRX] share price is $12.60. The Score for PLRX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
766.1M
Price in USD:
12.60
Share Volume:
691.51K
Pliant Therapeutics 52-Week Range
52-Week High:
19.62
52-Week Low:
10.29
Sell
39
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 12.60 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 12.60 while PLRX 8-day exponential moving average is 12.40, which is a Buy signal.
- The stock price of PLRX is 12.60 while Pliant Therapeutics 20-day EMA is 12.65, which makes it a Sell.
- Pliant Therapeutics 50-day exponential moving average is 12.72 while PLRX share price is 12.60, making it a Sell technically.
- PLRX stock price is 12.60 and Pliant Therapeutics 200-day simple moving average is 14.08, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.32 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Pliant Therapeutics is a Sell
- Pliant Therapeutics Relative Strength Index (RSI) is 48.91, which suggest Pliant Therapeutics is oversold
- The Bollinger Bands (25) for Pliant Therapeutics is (12.27 - 13.37), which suggest Pliant Therapeutics is a Sell
- The Bollinger Bands (100) for Pliant Therapeutics is (11.45 - 13.77), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.